Related Experiment Videos
A method for hepatic arterial perfusion studies in the rat.
T T Than1, J V Sitzmann, S S Li
1Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205.
The Journal of Surgical Research
|September 1, 1989
Summary
This study validates a rat model for hepatic arterial infusion therapy, optimizing drug delivery for pharmacokinetic research. Modifications ensure over 95% hepatic drug delivery without impacting blood flow.
Area of Science:
- Pharmacology
- Surgical Models
- Drug Delivery
Background:
- Selective hepatic arterial infusion is crucial for targeted liver drug delivery.
- Existing models require optimization for accurate pharmacokinetic studies.
- Understanding drug distribution is key in liver-directed therapies.
Purpose of the Study:
- To evaluate and refine a rat model for selective hepatic arterial infusion therapy.
- To ensure accurate drug delivery for short-term pharmacokinetic experiments.
- To assess the impact of model modifications on physiological parameters.
Main Methods:
- Cannulation of the common hepatic artery via the gastroduodenal artery in rats.
- Use of radioactive microspheres to determine hepatic perfusion and blood flow.
- Implementation of temporary proximal hepatic artery occlusion.
Main Results:
- High flow rates (2 ml/min) in the original model led to significant retrograde drug loss.
- Modified model with temporary hepatic artery occlusion achieved >95% hepatic drug delivery.
- Temporary occlusion did not adversely affect cardiac output or hepatic arterial blood flow.
Conclusions:
- The modified rat model with temporary hepatic artery occlusion is suitable for short-term pharmacokinetic studies.
- This model ensures reliable and targeted hepatic drug delivery.
- The findings support the use of this refined model in preclinical liver drug research.